The transcriptional landscape in thyroid cancer: current status of circulating biomarkers and liquid biopsy approaches

Expert Review of Anticancer Therapy · Published 2026-07-23 · DOI 10.1080/14737140.2026.2708770

Authors (4)

Srabonti Ghosh, Avik Chakraborty, Bhakti Basu, Sandip Basu

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Ghosh, S., Chakraborty, A., Basu, B., et al. (2026). The transcriptional landscape in thyroid cancer: current status of circulating biomarkers and liquid biopsy approaches. Expert Review of Anticancer Therapy. https://doi.org/10.1080/14737140.2026.2708770

Related articles

• The potential impact of glucagon-like peptide 1 receptor agonists for the treatment of endometrial carcinoma · Expert Review of Anticancer Therapy · 2026 · Same journal
• Emerging immune checkpoint inhibitor strategies in cervical cancer: a scoping review of ongoing clinical trials · Expert Review of Anticancer Therapy · 2026 · Same journal
• Portal vein resection in pancreatic cancer: from technical feasibility to biological patient selection · Expert Review of Anticancer Therapy · 2026 · Same journal
• The evolving survival landscape in advanced non-small cell lung cancer: an interrupted time series analysis · Expert Review of Anticancer Therapy · 2026 · Same journal
• Angiosarcoma: adaptive designs leveraging vascular biology and antiangiogenic repurposing · Expert Review of Anticancer Therapy · 2026 · Same journal
• Quantitative and qualitative fecal immunochemical tests for colorectal cancer screening in Kazakhstan: a comparative study · Expert Review of Anticancer Therapy · 2026 · Same journal
• Frailty is not ECOG: why performance status alone is no longer enough in anticancer therapy · Expert Review of Anticancer Therapy · 2026 · Same journal
• Can we consider stopping hepatocellular carcinoma surveillance in low-risk patients with hepatitis B? · Expert Review of Anticancer Therapy · 2026 · Same journal
• Association of neoadjuvant chemotherapy with outcomes in patients with elevated preoperative Ca 19–9 undergoing pancreatic ductal adenocarcinoma resection · Expert Review of Anticancer Therapy · 2026 · Same journal
• Cancer genome profiling in sarcomas: current status and future perspectives in Japan · Expert Review of Anticancer Therapy · 2026 · Same journal